- Home
- INKT vs BRNS Comparison
INKT vs BRNS Comparison
Compare INKT & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- BRNS
- Stock Information
- Founded
- INKT 2017
- BRNS 2016
- Country
- INKT United States
- BRNS United Kingdom
- Employees
- INKT N/A
- BRNS N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- BRNS Health Care
- Exchange
- INKT Nasdaq
- BRNS Nasdaq
- Market Cap
- INKT 69.2M
- BRNS 58.0M
- IPO Year
- INKT 2021
- BRNS 2021
- Fundamental
- Price
- INKT $14.59
- BRNS $1.51
- Analyst Decision
- INKT Buy
- BRNS Strong Buy
- Analyst Count
- INKT 3
- BRNS 1
- Target Price
- INKT $37.50
- BRNS $3.00
- AVG Volume (30 Days)
- INKT 39.9K
- BRNS 254.2K
- Earning Date
- INKT 11-13-2025
- BRNS 11-05-2025
- Dividend Yield
- INKT N/A
- BRNS N/A
- EPS Growth
- INKT N/A
- BRNS N/A
- EPS
- INKT N/A
- BRNS N/A
- Revenue
- INKT N/A
- BRNS $14,969,000.00
- Revenue This Year
- INKT N/A
- BRNS N/A
- Revenue Next Year
- INKT N/A
- BRNS N/A
- P/E Ratio
- INKT N/A
- BRNS N/A
- Revenue Growth
- INKT N/A
- BRNS 1766.46
- 52 Week Low
- INKT $4.56
- BRNS $0.64
- 52 Week High
- INKT $76.00
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- INKT 49.30
- BRNS 63.56
- Support Level
- INKT $14.10
- BRNS $1.36
- Resistance Level
- INKT $16.00
- BRNS $1.83
- Average True Range (ATR)
- INKT 1.05
- BRNS 0.17
- MACD
- INKT 0.04
- BRNS 0.05
- Stochastic Oscillator
- INKT 31.30
- BRNS 68.35
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.